Among 24 such systems (called devices in FDA parlance) authorized since 2015, FDA summaries for 14 lacked data on the ...

Science evolves as both controlled clinical research and real-world evidence show us how to use health care technologies to ...

Tempus AI (TEM) recently secured FDA clearance for its Tempus ECG-Low EF software and expanded its collaboration with Personalis for colorectal cancer detection, measures that collectively ...

AI was supposed to boost drug discovery, but progress has stalled. Learn why the hype hasn’t delivered and what needs to ...

A new technology that harnesses artificial intelligence (AI) to analyze mammograms and improve the accuracy of predicting a ...

At IAFP 2025, experts shared how AI and predictive modelling are now delivering tangible food safety outcomes across industry ...

Despite surging GenAI adoption in pharma and the FDA’s recent embrace of the technology, a trust gap remains with GenAI implementations. The story describes four essentials that improve trust in GenAI ...

Ultromics announced that it raised $55 million in a Series C financing to support its AI-powered heart failure diagnostic ...

Evaluating electrocardiogram (ECG) traces using a new deep-learning model known as EchoNext looks set to save lives by flagging patients at high risk of structural heart disease (SHD) who might ...

A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman's personalized ...

Transparency of evidence supporting Food and Drug Administration (FDA) authorization of artificial intelligence (AI)- and machine ...

The wearable, noninvasive CardioTag is designed to capture electrocardiogram, photoplethysmogram, and seismocardiogram signals, as well as heart rate and pulse rate.